Cognitive impairment and potential biological and psychological correlates of neuropsychological performance in recently orchiectomized testicular cancer patients

Psycho-Oncology

Volumn 24, Issue 9, 2015, Pages 1174-1180

  Amidi, Ali ^a   Wu, Lisa M ^b   Agerbæk, Mads ^a   Larsen, Patrick Londin ^a   Pedersen, Anders D ^c   Mehlsen, Mimi ^a   Larsen, Lars ^d   Zachariae, Robert ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c Vejlefjord Rehabilitation   (Denmark)

^d AARHUS UNIVERSITY   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; HYDROCORTISONE; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ANXIETY; ARTICLE; ATTENTION; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; DEPRESSION; HUMAN; LEARNING; MAJOR CLINICAL STUDY; MALE; NEUROPHYSIOLOGY; NEUROPSYCHOLOGICAL TEST; ORCHIECTOMY; POSTTRAUMATIC STRESS DISORDER; PROCESSING SPEED; STRESS; TESTIS CANCER; WORKING MEMORY; BLOOD; CASE CONTROL STUDY; COGNITIVE DYSFUNCTION; MIDDLE AGED; PATHOPHYSIOLOGY; PSYCHOLOGY; TESTICULAR NEOPLASMS;

ADULT; CASE-CONTROL STUDIES; COGNITIVE DYSFUNCTION; HUMANS; HYDROCORTISONE; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; ORCHIECTOMY; TESTICULAR NEOPLASMS;

EID: 84941169147     PISSN: 10579249     EISSN: 10991611     Source Type: Journal    
DOI: 10.1002/pon.3804     Document Type: Article

References (40)

1. Schagen SB, Boogerd W, Muller MJ, et al,. Cognitive complaints and cognitive impairment following BEP chemotherapy in patients with testicular cancer. Acta Oncol 2008; 47: 63-70. DOI: 10.1080/02841860701518058.
2. Pedersen AD, Rossen P, Mehlsen MY, Pedersen CG, Zachariae R, von dM,. Long-term cognitive function following chemotherapy in patients with testicular cancer. J Int Neuropsychol Soc 2009; 15: 296-301. DOI: 10.1017/S1355617709090316.
3. Skaali T, Fosså SD, Andersson S, et al,. A prospective study of neuropsychological functioning in testicular cancer patients. Ann Oncol 2011; 22: 1062-1070. DOI: 10.1093/annonc/mdq553.
4. Wefel JS, Vidrine DJ, Veramonti TL, et al,. Cognitive impairment in men with testicular cancer prior to adjuvant therapy. Cancer 2011; 117: 190-196. DOI: 10.1002/cncr.25298.
5. Wefel JS, Vidrine DJ, Marani SK, et al,. A prospective study of cognitive function in men with non-seminomatous germ cell tumors. Psycho-Oncology 2014; 23: 626-633. DOI: 10.1002/pon.3453.
6. Amidi A, Wu LM, Pedersen AD, et al,. Cognitive impairment in testicular cancer survivors 2 to 7 years after treatment. Support Care Cancer 2015; DOI: 10.1007/s00520-015-2663-3.
7. Trabert B, Chen J, Devesa SS, Bray F, McGlynn KA,. International patterns and trends in testicular cancer incidence, overall and by histologic subtype, 1973-2007. Andrology 2014; DOI: 10.1111/andr.293.
8. Dahl O, Brydøy M,. Testicular germ cell tumours-still many challenges. Acta Oncol 2012; 51: 147-150. DOI: 10.3109/0284186X.2011.653441.
9. Calvio L, Peugeot M, Bruns GL, Todd BL, Feuerstein M,. Measures of cognitive function and work in occupationally active breast cancer survivors. J Occup Environ Med 2010; 52: 219-227. DOI: 10.1097/JOM.0b013e3181d0bef7.
10. Wu LM, Austin J, Hamilton JG, et al,. Self-efficacy beliefs mediate the relationship between subjective cognitive functioning and physical and mental well-being after hematopoietic stem cell transplant. Psycho-Oncology 2012; 21: 1175-1184. DOI: 10.1002/pon.2012.
11. Wefel JS, Vardy J, Ahles T, Schagen SB,. International cognition and cancer task force recommendations to harmonise studies of cognitive function in patients with cancer. Lancet Oncol 2011; 12: 703-708. DOI: 10.1016/S1470-2045(10)70294-1.
12. Skaali T, Fosså SD, Dahl AA,. A prospective study of cognitive complaints in patients with testicular cancer. Clin Genitourin Cancer 2011; 9: 6-13. DOI: 10.1016/j.clgc.2011.04.002.
13. Skaali T, Fosså SD, Andersson S, Langberg CW, Lehne G, Dahl AA,. Is psychological distress in men recently diagnosed with testicular cancer associated with their neuropsychological test performance?. Psycho-Oncology 2011; 20: 369-377. DOI: 10.1002/pon.1737.
14. Lee BK, Glass TA, McAtee MJ, et al,. Associations of salivary cortisol with cognitive function in the Baltimore memory study. Arch Gen Psychiatry 2007; 64: 810-818. DOI: 10.1001/archpsyc.64.7.810.
15. Touitou Y, Bogdan A, Levi F, Benavides M, Auzeby A,. Disruption of the circadian patterns of serum cortisol in breast and ovarian cancer patients: relationships with tumour marker antigens. Br J Cancer 1996; 74: 1248-1252.
16. Wilson CJ, Finch CE, Cohen HJ,. Cytokines and cognition-the case for a head-to-toe inflammatory paradigm. J Am Geriatr Soc 2002; 50: 2041-2056.
17. Lippitz BE,. Cytokine patterns in patients with cancer: a systematic review. Lancet Oncol 2013; 14: e218-e228. DOI: 10.1016/S1470-2045(12)70582-X.
18. Kesler S, Janelsins M, Koovakkattu D, et al,. Reduced hippocampal volume and verbal memory performance associated with interleukin-6 and tumor necrosis factor-alpha levels in chemotherapy-treated breast cancer survivors. Brain Behav Immun 2013; 30 (Suppl): S109-S116. DOI: 10.1016/j.bbi.2012.05.017.
19. Heikkilä K, Ebrahim S, Lawlor DA,. A systematic review of the association between circulating concentrations of C reactive protein and cancer. J Epidemiol Community Health 2007; 61: 824-833. DOI: 10.1136/jech.2006.051292.
20. Roberts RO, Geda YE, Knopman DS, et al,. Association of C-reactive protein with mild cognitive impairment. Alzheimers Dement 2009; 5: 398-405. DOI: 10.1016/j.jalz.2009.01.025.
21. Nord C, Bjøro T, Ellingsen D, et al,. Gonadal hormones in long-term survivors 10 years after treatment for unilateral testicular cancer. Eur Urol 2003; 44: 322-328.
22. Mason SE, Noel-Storr A, Ritchie CW,. The impact of general and regional anesthesia on the incidence of post-operative cognitive dysfunction and post-operative delirium: a systematic review with meta-analysis. J Alzheimers Dis 2010; 22 (Suppl 3): 67-79. DOI: 10.3233/JAD-2010-101086.
23. Wechsler D,. Wechsler Adult Intelligence Scale-Fourth Edition. Pearson: San Antonio, TX, 2008.
24. Reitan RM,. Validity of the trail making test as an indicator of organic brain damage. Percept Mot Skills 1958; 8: 271-276.
25. Wiens AN, Fuller KH, Crossen JR,. Paced auditory serial addition test: adult norms and moderator variables. J Clin Exp Neuropsychol 1997; 19: 473-483. DOI: 10.1080/01688639708403737.
26. Rey A,. L'examen Clinique en Psychologie. Universitaires de France: Paris, France, 1964.
27. Benton AL, Hamsher KDS,. Multilingual Aphasia Examination. AJA Associates: Iowa City, 1989.
28. Heaton RK, Chelune GJ, Talley JL, Kay GG, Curtiss G,. Wisconsin Card Sorting Test Manual Revised and Expanded. Psychological Assessment Resources: Odessa, FL, 1993.
29. Zigmond AS, Snaith RP,. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983; 67: 361-370.
30. Cohen S, Kamarck T, Mermelstein R,. A global measure of perceived stress. J Health Soc Behav 1983; 24: 385-396.
31. Weiss DS, Marmar CR,. In The Impact of Event Scale-Revised. In Assessing Psychological Trauma and PTSD, Wilson JP, Keane TM, (eds). Guilford Press: New York, 1997; 399-411.
32. Broadbent DE, Cooper PF, FitzGerald P, Parkes KR,. The cognitive failures questionnaire (CFQ) and its correlates. Br J Clin Psychol 1982; 21 (Pt 1): 1-16.
33. Lange M, Giffard B, Noal S, et al,. Baseline cognitive functions among elderly patients with localised breast cancer. Eur J Cancer 2014; 50: 2181-2189. DOI: 10.1016/j.ejca.2014.05.026.
34. Valkanova V, Ebmeier KP, Allan CL,. CRP, IL-6 and depression: a systematic review and meta-analysis of longitudinal studies. J Affect Disord 2013; 150: 736-744. DOI: 10.1016/j.jad.2013.06.004.
35. Dantzer R, O'Connor JC, Freund GG, Johnson RW, Kelley KW,. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci 2008; 9: 46-56. DOI: 10.1038/nrn2297.
36. Pullens MJ, De Vries J, Roukema JA,. Subjective cognitive dysfunction in breast cancer patients: a systematic review. Psycho-Oncology 2010; 19: 1127-1138. DOI: 10.1002/pon.1673.
37. Ganz PA, Kwan L, Castellon SA, et al,. Cognitive complaints after breast cancer treatments: examining the relationship with neuropsychological test performance. J Natl Cancer Inst 2013; 105: 791-801. DOI: 10.1093/jnci/djt073.
38. Pomykala KL, Ganz PA, Bower JE, et al,. The association between pro-inflammatory cytokines, regional cerebral metabolism, and cognitive complaints following adjuvant chemotherapy for breast cancer. Brain Imaging Behav 2013; 7: 511-523. DOI: 10.1007/s11682-013-9243-2.
39. Kudielka BM, Schommer NC, Hellhammer DH, Kirschbaum C,. Acute HPA axis responses, heart rate, and mood changes to psychosocial stress (TSST) in humans at different times of day. Psychoneuroendocrinology 2004; 29: 983-992. DOI: 10.1016/j.psyneuen.2003.08.009.
40. Gass CS, Curiel RE,. Test anxiety in relation to measures of cognitive and intellectual functioning. Arch Clin Neuropsychol 2011; 26: 396-404. DOI: 10.1093/arclin/acr034.